Form 4 · Filed Jul 10, 2026, 08:44 PM UTC
ONC/BeOne Medicines Ltd.
Lee Chan Henry — SVP, General Counsel
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | M | other | 202 | $194 | $39,283 | 202 |
| Jul 8, 2026 | M | other | 266 | $213 | $56,743 | 468 |
| Jul 8, 2026 | M | other | 196 | $159 | $31,170 | 664 |
| Jul 8, 2026 | S | sell | 664 | $302 | $200,833 | 0 |
| Jul 8, 2026 | M | other | 2,626 | — | — | 17,238 |
| Jul 8, 2026 | M | other | 3,458 | — | — | 79,768 |
| Jul 8, 2026 | M | other | 2,548 | — | — | 105,300 |
Source: SEC EDGAR raw filing ↗ · Accession 0001980648-26-000017